Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
REGENERON PHARMACEUTICALS, INC.
| Metric | REGENERON PHARMACEUTICALS, INC. REGNOther |
|---|---|
| Quality Score | 87 / 100 |
| Revenue (latest) | $14.34B |
| Net income (latest) | $4.50B |
| Operating margin | 24.9% |
| Net margin | 31.4% |
| Return on equity | 14.4% |
| Return on assets | 11.1% |
| Return on capital (ROCE) | 9.9% |
| Debt / equity | 0.30× |
| Revenue growth (YoY) | 1.0% |
| Altman Z″ (distress) | 9.21 |
| Accruals / assets | −1.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.